Ranbaxy Pharmaceuticals Canada Inc. is recalling six lots of its prescription RAN-Metformin drug from the Canadian market. Company testing identified two lots (#AJY8006A and #AJY8007A) with levels of NDMA above what is considered acceptable if the drug were to be taken over a lifetime. The company is recalling an additional four lots (#AJY8005A, #AJY8005B, #AJY8008A...
Tag: Diabetes
Post
Discontinuation of Amaryl
Sanofi-aventis Canada announced in June, 2018 that it will immediately stop the distribution of Amaryl (Glimipiride) 1,2 and 4mg tabs in Canada. Glimepiride (original trade name Amaryl) is an orally available medium-to-long-acting Sulfonylurea antidiabetic drug.